• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clin Oral Investig . Prevalence of SARS-CoV-2 IgG antibodies among dental teams in Germany

tetano

Editor, Senior Moderator
Clin Oral Investig


. 2022 Jan 11.
doi: 10.1007/s00784-021-04363-z. Online ahead of print.
Prevalence of SARS-CoV-2 IgG antibodies among dental teams in Germany


Maria Mksoud[SUP] 1 [/SUP], Till Ittermann[SUP] 2 [/SUP], Birte Holtfreter[SUP] 3 [/SUP], Andreas Söhnel[SUP] 4 [/SUP], Carmen Söhnel[SUP] 5 [/SUP], Alexander Welk[SUP] 3 [/SUP], Lena Ulm[SUP] 6 [/SUP], Karsten Becker[SUP] 6 [/SUP], Nils-Olaf Hübner[SUP] 7 [/SUP], Andrea Rau[SUP] 5 [/SUP], Stefan Kindler[SUP] #[/SUP][SUP] 5 [/SUP], Thomas Kocher[SUP] #[/SUP][SUP] 3 [/SUP]



Affiliations

Abstract

Objectives: During the corona pandemic, dental practices temporarily closed their doors to patients except for emergency treatments. Due to the daily occupational exposure, the risk of SARS-CoV-2 transmission among dentists and their team is presumed to be higher than that in the general population. This study examined this issue among dental teams across Germany.
Materials and methods: In total, 2784 participants provided usable questionnaires and dry blood samples. Dry blood samples were used to detect IgG antibodies against SARS-CoV-2. The questionnaires were analyzed to investigate demographic data and working conditions during the pandemic. Multivariable logistic mixed-effects models were applied.
Results: We observed 146 participants with positive SARS-CoV-2 IgG antibodies (5.2%) and 30 subjects with a borderline finding (1.1%). Seventy-four out of the 146 participants with SARS-CoV-2 IgG antibodies did not report a positive SARS-CoV-2 PCR test (50.7%), while 27 participants without SARS-CoV-2 IgG antibodies reported a positive SARS-CoV-2 PCR test (1.1%). Combining the laboratory and self-reported information, the number of participants with a SARS-CoV-2 infection was 179 (6.5%). Though after adjustment for region, mixed-effects models indicated associations of use of rubber dams (OR 1.65; 95% CI: 1.01-2.72) and the number of protective measures (OR 1.16; 95% CI: 1.01-1.34) with increased risk for positive SARS-CoV-2 status, none of those variables was significantly associated with a SARS-CoV-2 status in fully adjusted models.
Conclusions: The risk of SARS-CoV-2 transmission was not higher among the dental team compared to the general population.
Clinical relevance: Following hygienic regulations and infection control measures ensures the safety of the dental team and their patients.

Keywords: Coronavirus; Epidemiology; Infection control; Occupational dentistry; Risk factor.
 
Back
Top Bottom